CXCR2 and neoplasm: In summary, we developed optimized CAR T cell protocols for generating canine B7-H3 CAR T cells and demonstrated the improved anti-tumor activity of dual CAR T cells expressing the B7-H3 CAR and the chemokine receptor CXCR2, in agreement with previous studies evaluating this construct in human CAR T cells.